FTIR microspectroscopy for improved prostate cancer diagnosis

Trends in Biotechnology

Volumn 27, Issue 12, 2009, Pages 661-663

  Mackanos, Mark A ^a   Contag, Christopher H ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL CHANGES; CANCER MANAGEMENT; DISEASE SEVERITY; FOURIER TRANSFORM INFRARED MICROSPECTROSCOPY; FTIR; FTIR MICROSPECTROSCOPY; OBSERVER ERRORS; PROSTATE CANCERS; PROSTATE TISSUE;

DISEASES; FOURIER TRANSFORM INFRARED SPECTROSCOPY;

DIAGNOSIS;

CANCER DIAGNOSIS; CANCER INVASION; CANCER STAGING; CANCER TISSUE; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; FOURIER TRANSFORM INFRARED MICROSPECTROSCOPY; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; OBSERVER VARIATION; PRIORITY JOURNAL; PROGNOSIS; PROSTATE BIOPSY; PROSTATE CANCER; SENSITIVITY AND SPECIFICITY; SHORT SURVEY; SPECTROSCOPY;

HISTOCYTOCHEMISTRY; HUMANS; MALE; PROSTATE; PROSTATIC NEOPLASMS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 70449378958     PISSN: 01677799     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tibtech.2009.09.001     Document Type: Short Survey

References (14)

1. Baker M.J., et al. FTIR-based spectroscopic analysis in the identification of clinically aggressive prostate cancer. Br. J. Cancer 99 (2008) 1859-1866
2. Chew S.F., et al. Fourier transform infrared imaging as a method for detection of HLA class I expression in melanoma without the use of antibody. Tiss. Antig. 69 (2007) 252-258
3. Podshyvalov A., et al. Distinction of cervical cancer biopsies by use of infrared microspectroscopy and probabilistic neural networks. Appl. Optics 44 (2005) 3725-3734
4. Wang T.D., et al. Detection of endogenous biomolecules in Barrett's esophagus by Fourier transform infrared spectroscopy. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 15864-15869
5. Li Q.B., et al. Diagnosis of gastric inflammation and malignancy in endoscopic biopsies based on Fourier transform infrared spectroscopy. Clin. Chem. 51 (2005) 346-350
6. Yano K., et al. Direct measurement of human lung cancerous and noncancerous tissues by Fourier transform infrared microscopy: can an infrared microscope be used as a clinical tool?. Analyt. Biochem. 287 (2000) 218-225
7. Krishna C.M., et al. FTIR and Raman microspectroscopy of normal, benign, and malignant formalin-fixed ovarian tissues. Analyt. Bioanalyt. Chem. 387 (2007) 1649-1656
8. Gazi E., et al. Applications of Fourier transform infrared microspectroscopy in studies of benign prostate and prostate cancer. A pilot study. J. Pathol. 201 (2003) 99-108
9. Argov S., et al. Inflammatory bowel diseases as an intermediate stage between normal and cancer: a FTIR-microspectroscopy approach. Biopolymers 75 (2004) 384-392
10. Sahu R.K., et al. Can Fourier transform infrared spectroscopy at higher wave numbers (mid IR) shed light on biomarkers for carcinogenesis in tissues?. J. Biomed. Optics 10 (2005) (5), article 054017
11. Bindig U., et al. Fibre-optic IR-spectroscopy for biomedical diagnostics. Spectroscopy 17 (2003) 323-344
12. Gleason D.F. The Veteran's Administration Cooperative Urological Research Group: histologic grading and clinical staging of prostatic carcinoma. In: Tannenbaum M. (Ed). Urologic Pathology: The Prostate (1977), Lee & Febiger 171
13. Lattouf J.B., and Saad F. Gleason score on biopsy: is it reliable for predicting the final grade on pathology?. BJU Int. 90 (2002) 694-698
14. Gazi E., et al. A correlation of FTIR spectra derived from prostate cancer biopsies with Gleason grade and tumour stage. Eur. Urol. 50 (2006) 750-761